Paper41327481
MicroRNA-29b-3p promotes endothelial cell inflammation via NTRK2/PI3K/NLRP3 pathway in Moyamoya disease.
Wei L and 9 others. Eur J Med Res, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. MicroRNA-29b-3p promotes endothelial cell inflammation via NTRK2/PI3K/NLRP3 pathway in Moyamoya disease. Papers, record 41327481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41327481
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- MicroRNA-29b-3p promotes endothelial cell inflammation via NTRK2/PI3K/NLRP3 pathway in Moyamoya disease.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| MicroRNAs | Major topic |
| Moyamoya Disease | Major topic |
| Endothelial Cells | Major topic |
| NLR Family, Pyrin Domain-Containing 3 Protein | Major topic |
| Phosphatidylinositol 3-Kinases | Major topic |
| Inflammation | Major topic |
| Receptor, trkB | Major topic |
| Humans | |
| Signal Transduction | |
| Membrane Glycoproteins |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2024C03281(SD2) | The Key Research and Development Program of Zhejiang Province | PubMed | ||
| 2022020304 | Ningbo Top Medical and Health Research Program | PubMed | ||
| 2024L003 | Ningbo Clinical Research Center for Emergency and Critical Diseases | PubMed |
Source PubMed
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35735031 | Laminar shear stress alleviates monocyte adhesion and atherosclerosis development via miR-29b-3p/CX3CL1 axis regulation. | J Cell Sci | 2022 | https://conductscience.org/library/papers/35735031 | PubMed |
| 2 | 32165827 | MicroRNA-29b-3p inhibits cell proliferation and angiogenesis by targeting VEGFA and PDGFB in retinal microvascular endothelial cells. | Mol Vis | 2020 | https://conductscience.org/library/papers/32165827 | PubMed |
| 3 | 35754359 | RNF213 loss of function reshapes vascular transcriptome and spliceosome leading to disrupted angiogenesis and aggravated vascular inflammatory responses. | J Cereb Blood Flow Metab | 2022 | https://conductscience.org/library/papers/35754359 | PubMed |
| 4 | 34279201 | Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment. | Curr Neuropharmacol | 2022 | https://conductscience.org/library/papers/34279201 | PubMed |
| 5 | 29343587 | Surgical Management of Moyamoya Disease. | Stroke | 2018 | https://conductscience.org/library/papers/29343587 | PubMed |
| 6 | 40268337 | Peripheral blood GATA2 expression impacts RNF213 mutation penetrance and clinical severity in moyamoya disease. | Stroke Vasc Neurol | 2025 | https://conductscience.org/library/papers/40268337 | PubMed |
| 7 | 26846755 | Moyamoya Disease: Epidemiology, Clinical Features, and Diagnosis. | J Stroke | 2016 | https://conductscience.org/library/papers/26846755 | PubMed |
| 8 | 32992193 | Vascular Smooth Muscle Cell Derived from IPS Cell of Moyamoya Disease - Comparative Characterization with Endothelial Cell Transcriptome. | J Stroke Cerebrovasc Dis | 2020 | https://conductscience.org/library/papers/32992193 | PubMed |
| 9 | 38018829 | Insights on Moyamoya Disease: Vascular Inflammation and Nuclear Autoschizis in Cranial Arteries. | Stroke | 2024 | https://conductscience.org/library/papers/38018829 | PubMed |
| 10 | 14687471 | Clinical and experimental pathology of Moyamoya disease. | Chin Med J (Engl) | 2003 | https://conductscience.org/library/papers/14687471 | PubMed |
| 11 | 35873760 | TGFβ1 as a Predictive Biomarker for Collateral Formation Within Ischemic Moyamoya Disease. | Front Neurol | 2022 | https://conductscience.org/library/papers/35873760 | PubMed |
| 12 | 36497052 | CircZXDC Promotes Vascular Smooth Muscle Cell Transdifferentiation via Regulating miRNA-125a-3p/ABCC6 in Moyamoya Disease. | Cells | 2022 | https://conductscience.org/library/papers/36497052 | PubMed |
| 13 | 35605621 | Moyamoya disease: diagnosis and interventions. | Lancet Neurol | 2022 | https://conductscience.org/library/papers/35605621 | PubMed |
| 14 | 29633884 | Gelatinolytic activity of autocrine matrix metalloproteinase-9 leads to endothelial de-arrangement in Moyamoya disease. | J Cereb Blood Flow Metab | 2018 | https://conductscience.org/library/papers/29633884 | PubMed |
| 15 | 36939771 | Recent Progresses in Electrochemical DNA Biosensors for MicroRNA Detection. | Phenomics | 2022 | https://conductscience.org/library/papers/36939771 | PubMed |
| 16 | 30101479 | SRPK1 gene silencing promotes vascular smooth muscle cell proliferation and vascular remodeling via inhibition of the PI3K/Akt signaling pathway in a rat model of intracranial aneurysms. | CNS Neurosci Ther | 2019 | https://conductscience.org/library/papers/30101479 | PubMed |
| 17 | 35401401 | Ring Finger Protein 213 in Moyamoya Disease With Pulmonary Arterial Hypertension: A Mini-Review. | Front Neurol | 2022 | https://conductscience.org/library/papers/35401401 | PubMed |
| 18 | 33941642 | Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study. | Stroke Vasc Neurol | 2021 | https://conductscience.org/library/papers/33941642 | PubMed |
| 19 | 26180604 | Epidemiology of Moyamoya Disease in Korea: Based on National Health Insurance Service Data. | J Korean Neurosurg Soc | 2015 | https://conductscience.org/library/papers/26180604 | PubMed |
| 20 | 35197402 | 2021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society. | Neurol Med Chir (Tokyo) | 2022 | https://conductscience.org/library/papers/35197402 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IL1B | 3553 | PubTator's text mining | https://conductscience.org/library/genes/3553 | NCBI Gene |
| NLRP3 | 114548 | PubTator's text mining | https://conductscience.org/library/genes/114548 | NCBI Gene |
| NTRK2 | 4915 | PubTator's text mining | https://conductscience.org/library/genes/4915 | NCBI Gene |
| PIK3CB | 5291 | PubTator's text mining | https://conductscience.org/library/genes/5291 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41327481
GET https://conductscience.org/api/papers/v1/41327481/references?page=2